Search research articles
Contact Us
Filters
Showing results (541-550 of 552) with videos related to
Page
of 56
Sort By:
Bioinformatics (Oxford, England)
|
February 10, 2023
The scalable precision medicine open knowledge engine (SPOKE): a massive knowledge graph of biomedical information
John H Morris, Karthik Soman, Rabia E Akbas, et al.
Circulation Research
|
March 30, 2012
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis
Harald F Langer, Eun Young Choi, Hong Zhou, et al.
Neurology
|
November 12, 2024
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States
Elizabeth Wilson, Huong D Meeks, Bradley J Barney, et al.
Nucleic Acids Research
|
October 30, 2016
The RCSB protein data bank: integrative view of protein, gene and 3D structural information
Peter W Rose, Andreas Prlić, Ali Altunkaya, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 15, 2024
Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study
Sarah K G Jensen, Susana Camposano, Anne Berens, et al.
Neurology
|
June 3, 2025
Epigenetic Aging in Pediatric-Onset Multiple Sclerosis
Christopher Goyne, Ashley E Fair, Defne Yilmaz, et al.
Plos Computational Biology
|
May 13, 2021
Ten simple rules to cultivate transdisciplinary collaboration in data science
Faryad Sahneh, Meghan A Balk, Marina Kisley, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 6, 2021
Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis
Benjamin M Greenberg, Theron Charles Casper, Soe S Mar, et al.
Genome Medicine
|
December 20, 2017
Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework
Gustavo Glusman, Peter W Rose, Andreas Prlić, et al.
Journal of Medicinal Chemistry
|
October 3, 2003
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics
Peter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Page
of 56
Search research articles
Search
Showing results (541-550 of 552) with videos related to
Sort By:
Page
of 56
Bioinformatics (Oxford, England)
|
February 10, 2023
The scalable precision medicine open knowledge engine (SPOKE): a massive knowledge graph of biomedical information
John H Morris, Karthik Soman, Rabia E Akbas, et al.
Circulation Research
|
March 30, 2012
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis
Harald F Langer, Eun Young Choi, Hong Zhou, et al.
Neurology
|
November 12, 2024
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States
Elizabeth Wilson, Huong D Meeks, Bradley J Barney, et al.
Nucleic Acids Research
|
October 30, 2016
The RCSB protein data bank: integrative view of protein, gene and 3D structural information
Peter W Rose, Andreas Prlić, Ali Altunkaya, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 15, 2024
Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study
Sarah K G Jensen, Susana Camposano, Anne Berens, et al.
Neurology
|
June 3, 2025
Epigenetic Aging in Pediatric-Onset Multiple Sclerosis
Christopher Goyne, Ashley E Fair, Defne Yilmaz, et al.
Plos Computational Biology
|
May 13, 2021
Ten simple rules to cultivate transdisciplinary collaboration in data science
Faryad Sahneh, Meghan A Balk, Marina Kisley, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 6, 2021
Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis
Benjamin M Greenberg, Theron Charles Casper, Soe S Mar, et al.
Genome Medicine
|
December 20, 2017
Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework
Gustavo Glusman, Peter W Rose, Andreas Prlić, et al.
Journal of Medicinal Chemistry
|
October 3, 2003
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics
Peter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Page
of 56